NuGene International, Inc. Announces New Study to Evaluate Wound Healing Efficacy

Nanjing Regenerative Medicine Engineering and Technology Research Center, Inc. to Perform Testing IRVINE, Calif., June 11, 2015 /PRNewswire/  NuGene International, Inc. ( NuGene ) (OTCQB: NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, has announced that it is initiating a study that will allow NuGene to evaluate a medication formulation as an improved method of treating burn wounds. The study, named Comparison of an Allantoin Formulation and Allantoin Formulation with Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing Protocol, will begin immediately and is scheduled to run through September 1, 2015 but may be extended if necessary. NuGene will provide the investigational new drug to be used in this study. The study will compare the effect of using Allontoin, a natural chemical compound that is produced by ma


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: